Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Current Taxes: 2022-2024

Historic Current Taxes for Arcturus Therapeutics Holdings (ARCT) over the last 1 years, with Mar 2024 value amounting to $979,000.

  • Arcturus Therapeutics Holdings' Current Taxes fell 29.97% to $979,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $979,000, marking a year-over-year decrease of 29.97%. This contributed to the annual value of $641,000 for FY2023, which is 50.50% down from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Current Taxes of $979,000 as of Q1 2024, which was up 52.73% from $641,000 recorded in Q4 2023.
  • In the past 5 years, Arcturus Therapeutics Holdings' Current Taxes registered a high of $1.4 million during Q1 2023, and its lowest value of $482,000 during Q3 2023.
  • Over the past 3 years, Arcturus Therapeutics Holdings' median Current Taxes value was $979,000 (recorded in 2024), while the average stood at $959,000.
  • Data for Arcturus Therapeutics Holdings' Current Taxes shows a maximum YoY slumped of 50.50% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Arcturus Therapeutics Holdings' Current Taxes stood at $1.3 million in 2022, then crashed by 50.50% to $641,000 in 2023, then decreased by 29.97% to $979,000 in 2024.
  • Its Current Taxes was $979,000 in Q1 2024, compared to $641,000 in Q4 2023 and $482,000 in Q3 2023.